Skip to main content
Journal cover image

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

Publication ,  Journal Article
McKenney, JM; Davidson, MH; Jacobson, TA; Guyton, JR; National Lipid Association Statin Safety Assessment Task Force,
Published in: Am J Cardiol
April 17, 2006

This article summarizes the final conclusions of the National Lipid Association (NLA) Statin Safety Task Force, based on a review and independent research of New Drug Application (NDA) information, US Food and Drug Administration (FDA) Adverse Event Reporting System (AERS) data, cohort and clinical trial results, and analysis of administrative claims database information and the assessment of its 4 Expert Panels, which focused on issues of statin safety with regard to liver, muscle, renal, and neurologic systems. Practical guidance in the form of recommendations to health professionals who manage the coronary artery disease risk of patients with statin therapy is provided.

Duke Scholars

Published In

Am J Cardiol

DOI

ISSN

0002-9149

Publication Date

April 17, 2006

Volume

97

Issue

8A

Start / End Page

89C / 94C

Location

United States

Related Subject Headings

  • Renal Insufficiency
  • Proteinuria
  • Peripheral Nervous System Diseases
  • Muscular Diseases
  • Liver Failure
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Dose-Response Relationship, Drug
  • Dementia
  • Databases, Factual
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McKenney, J. M., Davidson, M. H., Jacobson, T. A., Guyton, J. R., & National Lipid Association Statin Safety Assessment Task Force, . (2006). Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol, 97(8A), 89C-94C. https://doi.org/10.1016/j.amjcard.2006.02.030
McKenney, James M., Michael H. Davidson, Terry A. Jacobson, John R. Guyton, and John R. National Lipid Association Statin Safety Assessment Task Force. “Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.Am J Cardiol 97, no. 8A (April 17, 2006): 89C-94C. https://doi.org/10.1016/j.amjcard.2006.02.030.
McKenney JM, Davidson MH, Jacobson TA, Guyton JR, National Lipid Association Statin Safety Assessment Task Force. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol. 2006 Apr 17;97(8A):89C-94C.
McKenney, James M., et al. “Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.Am J Cardiol, vol. 97, no. 8A, Apr. 2006, pp. 89C-94C. Pubmed, doi:10.1016/j.amjcard.2006.02.030.
McKenney JM, Davidson MH, Jacobson TA, Guyton JR, National Lipid Association Statin Safety Assessment Task Force. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol. 2006 Apr 17;97(8A):89C-94C.
Journal cover image

Published In

Am J Cardiol

DOI

ISSN

0002-9149

Publication Date

April 17, 2006

Volume

97

Issue

8A

Start / End Page

89C / 94C

Location

United States

Related Subject Headings

  • Renal Insufficiency
  • Proteinuria
  • Peripheral Nervous System Diseases
  • Muscular Diseases
  • Liver Failure
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Dose-Response Relationship, Drug
  • Dementia
  • Databases, Factual